Matches in Wikidata for { <http://www.wikidata.org/entity/Q64637911> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q64637911 description "clinical trial" @default.
- Q64637911 description "ensayu clínicu" @default.
- Q64637911 description "klinisch onderzoek" @default.
- Q64637911 description "клінічне випробування" @default.
- Q64637911 description "կլինիկական փորձարկում" @default.
- Q64637911 name "A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab" @default.
- Q64637911 type Item @default.
- Q64637911 label "A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab" @default.
- Q64637911 prefLabel "A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab" @default.
- Q64637911 P1132 Q64637911-CA474A83-CDA5-4A8B-AEC0-15EF3661D67D @default.
- Q64637911 P1476 Q64637911-80A3195A-E043-4949-AAAB-33EC98689C3A @default.
- Q64637911 P17 Q64637911-505C51EF-038B-4552-B165-1BE9ECBDE858 @default.
- Q64637911 P17 Q64637911-5228721A-AAC6-45D2-8DD2-FCAE5464D12E @default.
- Q64637911 P17 Q64637911-88834169-F51D-4682-9EFB-039393F4B875 @default.
- Q64637911 P17 Q64637911-BF317C36-E814-4664-9091-7B964CA144D1 @default.
- Q64637911 P17 Q64637911-E4287015-49C7-403A-A7D2-EBF5FBE5C085 @default.
- Q64637911 P17 Q64637911-E8AD3359-A253-45BD-B522-CDEF4A4FEB95 @default.
- Q64637911 P2899 Q64637911-86743388-1314-42E0-BAFB-12AA2CE1B70B @default.
- Q64637911 P3098 Q64637911-A6B21223-17DF-4500-9712-540D181CB777 @default.
- Q64637911 P31 Q64637911-9666BC95-BC95-4AF3-831D-9E45D7F97533 @default.
- Q64637911 P580 Q64637911-6493373D-EA46-4B2C-90D7-53BA410B7C99 @default.
- Q64637911 P582 Q64637911-A5D19C56-8D04-4B26-A482-C8ABA1C2BA97 @default.
- Q64637911 P6099 Q64637911-C1565E26-8642-4F32-A5DA-BA05FED65020 @default.
- Q64637911 P6153 Q64637911-037CAC51-EDCA-42CC-9096-3560A79891E1 @default.
- Q64637911 P6153 Q64637911-1F41CD0D-7102-4F29-83E9-0A993534D746 @default.
- Q64637911 P6153 Q64637911-22318343-99A8-4ECF-A932-B701B9D0C615 @default.
- Q64637911 P6153 Q64637911-38FDDFE3-2944-4E71-9700-2DCBF18CC7BF @default.
- Q64637911 P6153 Q64637911-69841198-5F05-448E-8A64-540AAAF8C2EF @default.
- Q64637911 P6153 Q64637911-72E20745-4BC8-46D0-B9C5-10E1439DF4B5 @default.
- Q64637911 P6153 Q64637911-750AAFDE-9C3E-4F50-9436-06795254E76F @default.
- Q64637911 P6153 Q64637911-8B4FE8EB-4524-4687-A646-27BFE69FCB4C @default.
- Q64637911 P6153 Q64637911-A148D144-07DA-4C4F-B7B8-64E2BD7462E7 @default.
- Q64637911 P6153 Q64637911-D4AEBD9D-B188-4E73-9FBD-487CA0664275 @default.
- Q64637911 P6153 Q64637911-D8D68A3A-0653-488A-9EBC-85794243CE05 @default.
- Q64637911 P8363 Q64637911-826BA4D2-6F48-4D90-8AD7-E5477D060F8E @default.
- Q64637911 P1132 "+360" @default.
- Q64637911 P1476 "A Multicenter, Open-Label, Long-Term Safety Extension of Phase II Studies ABE4869g and ABE4955g in Patients With Mild to Moderate Alzheimer's Disease" @default.
- Q64637911 P17 Q142 @default.
- Q64637911 P17 Q145 @default.
- Q64637911 P17 Q16 @default.
- Q64637911 P17 Q183 @default.
- Q64637911 P17 Q29 @default.
- Q64637911 P17 Q30 @default.
- Q64637911 P2899 "+50" @default.
- Q64637911 P3098 "NCT01723826" @default.
- Q64637911 P31 Q30612 @default.
- Q64637911 P580 "2012-12-07T00:00:00Z" @default.
- Q64637911 P582 "2017-02-08T00:00:00Z" @default.
- Q64637911 P6099 Q42824440 @default.
- Q64637911 P6153 Q1130172 @default.
- Q64637911 P6153 Q2415975 @default.
- Q64637911 P6153 Q30269551 @default.
- Q64637911 P6153 Q30269704 @default.
- Q64637911 P6153 Q30270172 @default.
- Q64637911 P6153 Q30270309 @default.
- Q64637911 P6153 Q30270317 @default.
- Q64637911 P6153 Q4614 @default.
- Q64637911 P6153 Q49112 @default.
- Q64637911 P6153 Q5002619 @default.
- Q64637911 P6153 Q61931487 @default.
- Q64637911 P8363 Q78089383 @default.